Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01427452 · ClinicalTrials.gov registry record
Kidney Donor Outcomes Cohort (KDOC) Study
A clinical trial of Living Donor Nephrectomy, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 720
- Enrollment target
- 7
- Study locations
NCT01427452 is a study of Living Donor Nephrectomy that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 720 participants. The trial reports 7 study locations across 7 states.
The verdict
NCT01427452, a study of Living Donor Nephrectomy, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 720 participants
- Enrollment target
- 7
- Study locations
Study Summary
Live donor kidney transplantation (LDKT) is important because its outcomes for recipients are superior to those of deceased donor transplantation, and it yields significant cost savings to the healthcare system overall. Despite efforts over the past few decades to enhance understanding of the short- and long-term outcomes of living kidney donation, it is clear that investigators have more knowledge in some areas (e.g., surgical and medical complications) than in others (e.g., psychological outcomes, financial impact). While the transplant community and changes in federal regulations have brought attention to the need for more systematic study of living donor outcomes, there remains a paucity of scientifically rigorous multisite, prospective outcome studies. The long-term goal of this research program is to characterize the short- and long-term surgical, medical, functional, psychological, and financial outcomes of living kidney donation. The objective of this study is to establish a multisite prospective cohort of living kidney donors, their recipients, and a healthy comparison group. This cohort will be used to examine three primary aims: (1) to assess donor outcomes (surgical, medical, functional, psychological, financial) over a 2-year period initially, with the intention of examining these outcomes over a more extended time period in subsequent years; (2) to identify the donor, recipient, and center variables that are most predictive of donor outcomes; and (3) to identify disparities in donor outcomes and their predictors. To accomplish these aims, six kidney transplant programs, representing six states (Massachusetts, Maine, Rhode Island, New York, Iowa, and Arizona) and with experience and expertise in caring for living donors and transplant recipients, will participate in the study. Donors, their recipients, and healthy controls will complete comprehensive assessments at baseline (pre-surgery) and at 1, 6, 12, and 24 months post-donation. This study will exte
Conditions Studied
Study Locations (7)
Arizona
- University of Arizona - Tucson
Iowa
- University of Iowa - Iowa City
Maine
- Maine Medical Center - Portland
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
New York
- Montefiore Medical Center - The Bronx
Ohio
- Cleveland Clinic - Cleveland
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 720 participants |
| Start Date | 2011-08 |
| Est. Completion | 2018-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01427452
The ClinicalTrials.gov registry entry for NCT01427452 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Living Donor Nephrectomy appearing as the primary indexed condition, and to 0 interventions.
NCT01427452 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Arizona, Iowa, Maine.
Frequently Asked Questions
What is clinical trial NCT01427452 about?
NCT01427452 is a clinical study titled "Kidney Donor Outcomes Cohort (KDOC) Study". Live donor kidney transplantation (LDKT) is important because its outcomes for recipients are superior to those of deceased donor transplantation, and it yields significant cost savings to the healthcare system overall. Despite efforts over the past few decades to enhance understanding of the short-...
What is the current status of trial NCT01427452?
This trial is currently completed. The enrollment target is 720 participants. The study started on 2011-08. Estimated completion is 2018-02.
What conditions does trial NCT01427452 study?
This clinical trial studies the following conditions: Living Donor Nephrectomy.
Who is sponsoring clinical trial NCT01427452?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01427452 being conducted?
This trial has 7 study locations across Arizona, Iowa, Maine, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.